文献速递前列腺癌

高强度聚焦超声部分消融后局部复发行挽救性根治性前列腺切除术的病理发现与磁共振成像一致性

Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound.
PubMed 文献 · J Urol · 2019-01-01

研究纳入2012至2018年35例高强度聚焦超声部分消融后行挽救性机器人辅助根治性前列腺切除术的男性,比较消融前与挽救术前临床病理特征与挽救术病理。挽救术病理显示97.1%术野内、81.3%术野外存在ISUP≥2显著癌,82.4%较消融前不利重分类,切缘阳性率40.0%,磁共振对术野内和术野外复发灵敏度分别为81.8%和60.7%。作者认为挽救性机器人辅助根治性前列腺切除术可能较初次手术有更高的切缘阳性、升级和升期风险。

要点

  • 挽救术病理示术野内97.1%、术野外81.3%存在ISUP≥2显著癌。
  • 82.4%病例在挽救术时较消融前不利重分类,切缘阳性率40.0%。
  • 磁共振对术野内和术野外复发灵敏度分别为81.8%和60.7%。

核心结论

  • 挽救性机器人辅助根治性前列腺切除术可能较初次机器人辅助根治性前列腺切除术有更高的切缘阳性、升级和升期风险。
  • 高强度聚焦超声存在消融区内和消融区外复发的风险。
  • 该信息可能有助于挽救手术规划和关于初始治疗选择及高强度聚焦超声后挽救治疗的患者咨询。

研究设计与样本

  • 2012至2018年35例男性在高强度聚焦超声部分消融后接受挽救性机器人辅助根治性前列腺切除术。
  • 比较超声前与超声后挽救术前临床病理特征与挽救性前列腺切除术组织病理学。
  • 评估术野内复发、术野外病变、切缘阳性及挽救性机器人辅助根治性前列腺切除术前的磁共振灵敏度。

主要发现

  • 高强度聚焦超声前55.9%男性为多灶性疾病,47.1%在治疗野外有Gleason 3+3疾病。
  • 挽救性前列腺切除术中位时间16个月(IQR 11-26)。
  • 挽救性前列腺切除术指征为术野内复发55.8%、术野外复发20.6%、术野内和术野外复发23.5%。
  • 挽救术病理示ISUP≥2显著癌术野内97.1%、术野外81.3%、术野内和术野外79.4%。
  • 82.4%病例在挽救术时较超声前67.6%不利重分类;切缘阳性率40.0%。

关键数值与推荐

  • 切缘阳性中84.6%位于既往超声区域,尽管广泛切除,包括pT2 28.6%、pT3 47.6%及大小≥3 mm、pT3或多灶(即显著)31.4%。
  • 超声后磁共振对术野内和术野外复发的灵敏度分别为81.8%和60.7%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We describe the pathological characteristics of recurrence following high intensity focused ultrasound partial ablation in men treated with salvage robot-assisted radical prostatectomy. We assessed the sensitivity of magnetic resonance imaging before salvage robot-assisted radical prostatectomy in these men. MATERIALS AND METHODS: A total of 35 men underwent salvage robot-assisted radical prostatectomy after high intensity focused ultrasound partial ablation from 2012 to 2018. We compared clinicopathological characteristics before ultrasound and before salvage prostatectomy after ultrasound to histopathology on salvage prostatectomy. We assessed infield recurrence, out of field disease, positive surgical margins and magnetic resonance imaging sensitivity before salvage robot-assisted radical prostatectomy. RESULTS: Before high intensity focused ultrasound 55.9% of men had multifocal disease and 47.1% had Gleason 3 + 3 disease outside the treatment field. Median time to salvage prostatectomy was 16 months (IQR 11-26). Indications for salvage prostatectomy were infield recurrence in 55.8% of cases, out of field recurrence in 20.6%, and infield and out of field recurrence in 23.5%. On salvage prostatectomy histopathology revealed significant cancer, defined as ISUP (International Society of Urological Pathology) 2 or greater, infield in 97.1% of cases, out of field in 81.3%, and infield and out of field in 79.4%. Of the cases 82.4% were adversely reclassified at salvage prostatectomy compared to 67.6% before ultrasound. The positive surgical margin rate was 40.0%. Of the positive margins 84.6% were in the region of previous ultrasound despite wide excision, including pT2 in 28.6%, pT3 in 47.6% and size 3 mm or greater, pT3 or multifocal (ie significant) in 31.4%. After ultrasound the sensitivity of magnetic resonance imaging for infield and out of field recurrence was 81.8% and 60.7%, respectively. CONCLUSIONS: Salvage robot-assisted radical prostatectomy may confer a higher risk of positive surgical margins, upgrading and up-staging than primary robot-assisted radical prostatectomy. High intensity focused ultrasound carries a risk of recurrence inside and outside the ablation zone. This information may inform salvage surgical planning and patient counseling regarding the choice of initial therapy and salvage treatment after high intensity focused ultrasound.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Thompson JE, Sridhar AN, Tan WS, et al. Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound. J Urol. 2019. PMID: 30730409. doi:10.1097/JU.0000000000000135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。